BI-6015
CAS No. 93987-29-2
BI-6015( BI 6015 | BI6015 )
Catalog No. M27480 CAS No. 93987-29-2
BI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 192 | In Stock |
|
| 50MG | 286 | In Stock |
|
| 100MG | 429 | In Stock |
|
| 500MG | 888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-6015
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.
-
DescriptionBI 6015 is an antagonist of HNF4α. HNF4α is a nuclear receptor that regulates gene expression in the intestine cells, liver cells, and pancreas-β cells.
-
In VitroCell Viability Assay Cell Line:Hep3B-Luc cells and primary hepatocytes Concentration:1.25, 2.5, 5, 10, 20 μM Incubation Time:24, 48, 72 hours Result:Was markedly toxic to Hep3B cells but spared primary hepatocytes.
-
In Vivo——
-
SynonymsBI 6015 | BI6015
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number93987-29-2
-
Formula Weight331.35
-
Molecular FormulaC15H13N3O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (150.90 mM)
-
SMILESCc1nc2ccccc2n1S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haf?z AM, et al. Protective and therapeutic effects of pyrrolidine dithiocarbamate in a rat tongue cancer model created experimentally using 4-nitroquinoline 1-oxide. Adv Clin Exp Med. 2020 Nov;29(11):1249-1254.
molnova catalog
related products
-
3-Galloylquercitrin
1. 3''-Galloylquercitrin possesses the activity for PTK inhibition.
-
L-Asparaginase
L-Asparaginase (L-?ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.
-
NSC45586
NSC45586 is a protein phosphatase PHLPP inhibitor, which is selective for PHLPP1 and PHLPP2.
Cart
sales@molnova.com